Post by
Adventurous on May 17, 2024 10:46am
The New Game
Tilray is today reportedly issuing shares to get ready for the cannabis reclassification. This is probably not to buy weed farms. The industry is plagued with over-production. The new game will be all about reducing costs by controlling strategic segments of the industry, like cannabis oil production.
Nextleaf is more than ever a seating duck. Poison pill and big players being temporary out of cash aside. Already profitable and with a unique dominating technology. Ready to be bought-out.
To my callls on this board for the new CEO to be more strategically active, she answered that Nextleaf was already providing key ingredients to the firms exporting from Canada. The coming Q results will probably show that Nextleaf is indeed gaining market shares in all jurisdictions.
All nice and good, for now. Counting beans. But nothing so far about finding a strategic partner to export our technology to the US. About finding Big Pharma partners, since our technology allows us to produce big standardized quantities reportedly like no one else.
Missing Paul.
Comment by
Adventurous on May 17, 2024 2:38pm
Curaleaf CEO summing up the situation and talking M&A: Curaleaf is looking at tax savings of over $150 million a year: Curaleaf CEO - Video - BNN
Comment by
Dynaboy72 on May 17, 2024 6:49pm
So who would you like to buy out nextleaf? I think with the connections the board members have when the time is right will be a no brainer and they will do what's best for the company.I like Paul also but on ward and upward Emma is doing a awesome job earnings will speak for itself!